Marty Makary is out, and the Trump administration has a long wish list for its next FDA commissioner.

His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.

Marty Makary resigned as FDA commissioner Tuesday. The next commissioner will inherit the same punishing contradictions, and a weaker, politicized agency.